top of page

Extended Longevity

IRB 2021-2023.

The Longevinaut Study #1
 

THE SAFETY AND EFFECTIVENESS OF THE EXTENDED LONGEVITY

PROTOCOL ON THE EPIGENETIC AGING RATE IN HEALTHY INDIVIDUALS

Protocol Number: TD-EL-001

IRB approval number: IRCM-2019-285

Click here for Study

Conducted by

Quantum Functional Medicine of Carlsbad, California

Dr. Juergen Winkler, MD

Through the Institute of Regenerative and Cellular Medicine (IRCM) of Santa Monica,

California, Executive Director Dr. Barbara Krutchkoff, PhD

An Institutional Review Board (IRB) has been conducted by Dr. Juergen Winkler of Quantum Functional

Medicine of Carlsbad, California, under the auspices of the Institute of Regenerative and Cellular

Medicine (IRCM) of Santa Monica, California, sponsored by Extended Longevity, Inc. of Kula, Hawaii,

in support of the Extended Longevity Protocol in a study to demonstrate the reversal of three primary

biomarkers measuring the ten (10) determinant factors of aging.

The final report for Longevinaut Study #1 includes a cohort of 11 men and women ages 55–75 who have

taken the Extended Longevity Protocol daily for up to one year.

bottom of page